Health News Releases

January 15, 2014 18:24

BioGaia: New Study Indicates It’s Possible to Prevent Colic in Healthy Infants

A study of 468 healthy newborns shows that infants given the probiotic Lactobacillus reuteri Protectis cried less than half as long as infants given a placebo. The infants given Lactobacillus reuteri

January 15, 2014 17:00

Quintiles Receives Technology Security Award from IDG’s CSO Magazine

Quintiles(http://www.quintiles.com/news) announced today that it has been named to the 2014 CSO40 by IDG's CSO magazine for the second year in a row, recognizing its “Trusted Cloud Services Model” whi

January 14, 2014 17:35

Biotoscana agrees to acquire United Medical to expand commercial presence in Brazil and create a leading regional specialty pharmaceutical company in South America

Grupo Biotoscana SL, a pharmaceutical company based in Bogotá, Colombia, and majority owned by Advent International and Essex Woodlands, today announced that it has signed an agreement to acquire Unit

January 10, 2014 11:40

First International Consensus Guidelines Published for KCI Negative Pressure Wound Therapy with Instillation

Kinetic Concepts, Inc. (KCI) announced today the publication of the first International Consensus Guidelines for its Negative Pressure Wound Therapy with Instillation (NPWTi).[1] The guidelines appear

January 09, 2014 16:50

Patients Get Safety Information, Pill Reminders with New Mobile App from Quintiles

Information about potential adverse reactions from multiple medicines and a pill reminder which can be set for hourly, daily or weekly alerts, are some of the features on a new mobile app created by Q

January 08, 2014 15:25

Quintiles’ Fourth Quarter 2013 Earnings Call Scheduled for Thursday, February 13th

Quintiles Transnational Holdings Inc. (NYSE: Q) will release its financial results for the fourth quarter of 2013 prior to its investor call on Thursday, February 13, 2014, at 8 a.m. EST to discuss fo

January 08, 2014 10:51

Astellas to Form Strategic Partnership With ClearPath To Build Vaccine Portfolio

Astellas Pharma Inc. (Astellas) and ClearPath Development Company (ClearPath) announced today a strategic partnership to form a portfolio of development companies focused on vaccines targeting infecti

January 08, 2014 09:42

ABRAXANE® Plus gemcitabine Receives European Marketing Authorization for First-Line Treatment of Patients with Metastatic Pancreatic Cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the European Commission (EC) has granted approval for ABRAXANE (paclitaxel formulated

January 07, 2014 12:55

GE To Expand in Life Sciences with Acquisition of Strategic Assets from Thermo Fisher Scientific

GE (NYSE:GE) and Thermo Fisher Scientific (NYSE:TMO) announced today that they have entered into an agreement for GE Healthcare to acquire Thermo Fisher’s HyClone™ cell culture media and sera, and gen

January 07, 2014 10:50

Quintiles Executive to Present at J.P. Morgan Healthcare Conference

Quintiles CEO Tom Pike will present at the 2014 J.P. Morgan Healthcare Conference on Wednesday, January 15, 2014 in San Francisco at the Westin St. Francis Hotel. The Quintiles presentation will b

December 26, 2013 09:10

Menicon, Azabu University, and Yokohama City University Identify the Glaucoma Susceptibility Gene SRBD1 in Dogs

Menicon announces that an article entitled, “Dogs and humans share a common susceptibility gene SRBD1 for glaucoma risk”, which presents the results of a study conducted by Menicon, Azabu University,

December 23, 2013 11:54

iHerb Wins 2013 Best International Business Mobile Website

iHerb.com, a leading online retailer of nutritional supplements and wellness products announced today that it won the 2013 Best International Business Mobile Website from The Web Marketing Association

December 23, 2013 10:18

First-in-Man Implantation of CARMAT’s Bioprosthetic Artificial Heart

CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart project, providing an alternative for people suffering from end-stage heart f

December 19, 2013 10:33

Octapharma Phase II/III trial for the targeted treatment of relapsing multiple sclerosis enrols first patients

Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsi

December 18, 2013 14:31

Richard Relyea Elected to the Quintiles Transnational Holdings Inc. Board of Directors

Quintiles announced today that Mr. Richard Relyea has been elected to its board of directors. Mr. Relyea was designated by equity investor 3i to fill a vacancy on the Quintiles Transnational Holdin

December 18, 2013 10:31

61% of Life Sciences Execs Identify “Changing Commercial Business Model” as Major Pain Point in Survey by Cegedim Relationship Management

Cegedim Relationship Management today announced the release of their latest thought leadership report, 2013 Global Life Sciences Insights, which offers an analysis of the results of a global survey of

December 18, 2013 09:13

New data on safety and efficacy of Pradaxa® in treatment of acute deep vein thrombosis and pulmonary embolism

For media outside of the US, the UK & Canada only New pooled safety data from the RE-COVERTM and RE-COVERTM II phase III trials in acute deep vein thrombosis (DVT) and pulmonary embolism (PE) cons

December 16, 2013 18:14

Hepatitis C: Phase III data show Boehringer Ingelheim’s faldaprevir* is effective even in patients with common drug-resistant viral variant

For media outside of the US, the UK & Canada only Data show that Boehringer Ingelheim’s second-generation protease inhibitor faldaprevir*, when used in combination with pegylated interferon and ri

December 13, 2013 15:40

Quintiles Appoints Scott Evangelista to Lead Integrated Commercial Services and Solutions

Quintiles today announced the appointment of W. Scott Evangelista to serve as president, Integrated Commercial Services and Solutions. In this role, Evangelista is responsible for leading Quintiles’ g

December 13, 2013 09:40

Iroko Pharmaceuticals Enters into Strategic Agreements to Expand Commercialization of ZORVOLEXTM (diclofenac) Outside the U.S.

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that its affiliate, Iroko Pharmaceuticals Inc., has signed licens

December 12, 2013 09:00

Heartbeat Experts Reports Company wide Sales Growth of 44% and Over 600% Sales Growth in its Market Access Division

Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, today announced 44 percent sales growth during first three quarters of 2013. Heartbeat Expert’s

December 12, 2013 08:40

New Data Presented at ASH Annual Meeting Enhance Understanding of PNH and aHUS to Provide Optimal Care for Patients with These Life-threatening Disorders

CHESHIRE, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that researchers presented data from clinical trials demonstrating the clinical benefits of chronic Soli

December 11, 2013 10:30

electroCore's non invasive VNS treatment for headache highlighted at the recent American Headache Society (AHS) Annual Scottsdale Headache Symposium and the 17th Annual North American Neuromodulation Society (NANS) meeting

electroCore’s non invasive vagus nerve stimulation therapy for the prevention and treatment of cluster headache and migraine was reviewed at both the AHS Annual Scottsdale Headache Symposium (Nov 21st

December 11, 2013 09:30

New data analyses show consistent efficacy and safety profile of Pradaxa® in broad range of patients with acute deep vein thrombosis or pulmonary embolism*

For media outside of the US, the UK & Canada only New data analyses show that the positive treatment effect (efficacy and safety profile) of Pradaxa® (dabigatran etexilate) 150mg twice daily was c

December 10, 2013 14:25

Lincor Upgrades Patient Engagement Technology, Launches New Product Portfolio

Lincor Solutions today announced the launch of a new portfolio of products for delivering its industry-leading patient engagement technology to hospitals and health systems. Powered by next-generat

News by Region

News by Industry